Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

The Surveillance for Emerging Threats to Mothers and Babies Network conducts longitudinal surveillance of pregnant persons in the United States with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection during pregnancy. Of 6,551 infected pregnant persons in this analysis, 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffin, Isabel, Woodworth, Kate R., Galang, Romeo R., Burkel, Veronica K., Neelam, Varsha, Siebman, Samantha, Barton, Jerusha, Manning, Susan E., Aveni, Kathryn, Longcore, Nicole D., Harvey, Elizabeth M., Ngo, Van, Mbotha, Deborah, Chicchelly, Sarah, Lush, Mamie, Eckert, Valorie, Dzimira, Paula, Sokale, Ayomide, Valencia-Prado, Miguel, Azziz-Baumgartner, Eduardo, MacNeil, Adam, Gilboa, Suzanne M., Tong, Van T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962892/
https://www.ncbi.nlm.nih.gov/pubmed/35213801
http://dx.doi.org/10.3201/eid2804.212354
Descripción
Sumario:The Surveillance for Emerging Threats to Mothers and Babies Network conducts longitudinal surveillance of pregnant persons in the United States with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection during pregnancy. Of 6,551 infected pregnant persons in this analysis, 142 (2.2%) had positive RNA tests >90 days and up to 416 days after infection.

Ejemplares similares